Medical textbooks published before the late 20th century frequently omitted the clitoris entirely. When it appeared, it was often described in terms of its embryological relationship to the penis — defined by its resemblance to male anatomy rather than by its own structure and function. It was not until 1998 that the Australian urologist Helen O’Connell published the first comprehensive anatomical mapping of the clitoris using dissection and MRI — a structure that had been part of human female anatomy for as long as humans had existed, studied properly for the first time at the end of the 20th century.
This is the context in which claims about female sexual pleasure and health need to be understood. A medical system that did not study the anatomy of female pleasure could not have researched its health implications systematically. We are now in the early stages of doing that research, and what it shows is worth knowing.
What Female Pleasure Physically Is
The clitoris is significantly larger than its visible external portion. O’Connell’s 1998 research, extended in 2005 with MRI imaging, showed that the clitoris extends internally approximately 10 centimeters in most adult women, surrounding the vaginal walls with erectile tissue in a wishbone structure. The “internal” and “vaginal” orgasms that have generated decades of debate may be, in anatomical terms, clitoral stimulation of differently located portions of the same structure.
This matters for health research because imprecise anatomical understanding has produced imprecise research. Studies of “vaginal orgasm” vs. “clitoral orgasm” may have been measuring different types of stimulation of the same organ, and conclusions about the health benefits of one vs. the other need to be interpreted accordingly.
The physiological response cycle of female sexual arousal was first described systematically by Masters and Johnson in the 1960s — work that was groundbreaking for its time but conducted with significant methodological limitations, including the selection of easily orgasmic women as research subjects. Subsequent research has refined the picture considerably: arousal involves increased genital blood flow, vaginal transudation (the physiological equivalent of erection), elevation of pain thresholds, and activation of multiple brain regions including those involved in attention, memory, and the modulation of emotion.
The Research on Orgasm and Health
The research on orgasm and health in women is growing but still limited compared to the equivalent research in men — a disparity that reflects the research priorities described in our health pillar article.
Cardiovascular effects. Sexual activity, including masturbation, is associated with elevated heart rate, blood pressure, and cardiovascular workup comparable to moderate exercise. Research by Stuart Brody and Tillmann Krüger published in Psychophysiology found that partnered sex was associated with greater stress reactivity reductions than masturbation in some measures, though the mechanism is not fully understood. A prospective study of older women found that those who reported satisfying sex lives had lower rates of cardiovascular disease.
Pain modulation. The elevation of pain thresholds during sexual arousal is well-documented. Research has found that pain thresholds increase significantly during sexual arousal and reach their peak at orgasm. For women with dysmenorrhea (painful menstruation) and related conditions, there is evidence — limited but consistent — that orgasm can provide temporary pain relief. The mechanism involves oxytocin and endorphin release as well as direct modulation of pain signaling through arousal-activated pathways.
Immune function. A series of studies by Carl Charnetski and Francis Brennan found associations between frequency of sexual activity and levels of secretory IgA, an immunoglobulin involved in mucosal immune defense. The finding — more sexual activity associated with higher IgA — has been replicated in limited studies. The mechanism is hypothesized to involve oxytocin, DHEA, and other hormones associated with sexual activity.
Sleep. Orgasm is associated with the release of oxytocin, prolactin, and endorphins — all of which promote relaxation and sleep. Survey research consistently finds that women report improved sleep following orgasm, whether partnered or through masturbation. The physiological sleep-promoting mechanism is credible.
Pelvic floor health. Sexual arousal and orgasm involve complex pelvic floor muscle activity — contraction, relaxation, and repeated tonic contraction during orgasm. Research by physical therapists specializing in pelvic health has found that regular sexual activity, and specifically orgasm, may contribute to pelvic floor tone in ways that protect against incontinence. This is an area of active research.
Mental health. The relationship between sexual satisfaction and mental health is complex and bidirectional — mental health affects sexual function and sexual satisfaction affects mental health. But the direction of independent effect is real: studies controlling for baseline mental health find that sexual satisfaction is an independent predictor of life satisfaction, relationship quality, and positive mood. Research by Amy Muise and colleagues has found that “sexual communal motivation” — the motivation to respond to a partner’s sexual needs — is associated with relationship satisfaction in women even when their own desire is lower, but that women’s own sexual satisfaction is independently associated with wellbeing.
The Orgasm Gap
Research consistently finds a significant gap in orgasm frequency between women and men in heterosexual sexual encounters. A 2017 study by David Frederick and colleagues, published in Archives of Sexual Behavior and based on a large sample of American adults, found that men reported orgasming in 95% of sexual encounters, while women reported orgasming in 65%. In casual sex encounters, the gap was larger.
The gap was considerably smaller for lesbian women, who reported orgasming at rates comparable to heterosexual men. This finding is informative: it suggests that the gap is not primarily biological (if female orgasm were simply more difficult to achieve regardless of context, lesbian women would show a similar gap). It reflects a combination of knowledge, attention, and technique — specifically, who knows what women need for orgasm and is motivated to provide it.
Research by Elisabeth Lloyd, in her 2005 book The Case of the Female Orgasm, contributed an important evolutionary perspective: unlike male orgasm, which is directly mechanistically linked to reproduction, female orgasm is not required for conception. This led Lloyd to argue that female orgasm is not an adaptation but a byproduct of the developmental program that produces male orgasm (a kind of female “nipple equivalent”). Other evolutionary researchers have proposed adaptive accounts — that female orgasm functions as mate selection mechanism, a paternity assurance mechanism, or a bonding mechanism. The evolutionary debate is unsettled.
What is not unsettled is that female orgasm is a real physiological event with real health correlates, and the systematic under-attention to it in both medicine and cultural practice has costs.
What Medicine Has Suppressed
The history of medical treatment of female sexuality is not a neutral story. The 19th century saw the widespread treatment of “hysteria” — an ill-defined condition applied to women with a wide range of symptoms — by genital massage leading to “hysterical paroxysm” (what we would now recognize as medically induced orgasm), performed by physicians. This is sometimes cited as evidence that Victorian medicine was sexually liberal. It was not: the treatment reflected the medical view that female sexuality had no legitimate pleasure component, that the genital response was a medical intervention rather than an erotic experience, and that female “nervous complaints” could be managed through an interventional procedure.
The pathologization of female sexuality extended to what was not done as well as what was. Clitoral stimulation as a legitimate component of healthy sexual function was systematically absent from medical education and clinical advice for decades. When the American Psychiatric Association removed homosexuality from the DSM in 1973, it simultaneously reclassified female orgasmic disorder in ways that have been criticized for their assumption that heterosexual penetrative sex should be sufficient for orgasm — in the face of evidence that it is not, for most women.
Female sexual dysfunction remains a complex clinical and commercial area. The development of FDA-approved treatments for hypoactive sexual desire disorder (HSDD) in women — flibanserin, approved in 2015; bremelanotide, approved in 2019 — has been controversial. Critics have argued that these drugs were developed to create a market for a “pink Viagra” by medicalizing normal variation in female desire. Proponents argue that genuine HSDD causes real distress and deserves treatment. Both can be partially true.
What We Now Know
The research supports several conclusions that should probably be more widely known.
Female sexual pleasure is not trivially achievable and does not reliably occur through intercourse alone for most women — studies consistently find that the majority of women do not orgasm through penetration alone. This is anatomically explicable and clinically important, and it has been poorly communicated both medically and culturally.
Female sexual pleasure has documented health benefits across multiple systems, though the research is less complete than for men. The benefits are likely greatest for women who experience regular sexual activity including orgasm, and who experience that activity in contexts characterized by feeling seen, respected, and genuinely attended to.
The health benefits of sexual pleasure are not confined to partnered sex. Masturbation produces comparable physiological responses to partnered sex for most measured outcomes, without the interpersonal variables. The historical and continuing cultural shame around female masturbation has no health justification.
And the medical system’s relationship to female sexual pleasure — characterized by centuries of suppression, pathologization, and neglect — is slowly changing. It is changing partly because women are demanding that it change, and partly because the research, when done, consistently finds that female pleasure matters to female health.
Related reading on Vanity-X: